FIELD: medicine; surgery.
SUBSTANCE: for this purpose in case of surgery medicinal agent "Ferrovir" is intramuscularly injected as 1.5% solution in dosage 5.0 ml 2 times a day during 10 days. Conservative ferrovir-based therapy of destructive pancreatitis in specified dosage and injection rate is prescribed in 3 days following enzyme toxemia and systemic inflammatory reaction syndrome relief.
EFFECT: complex normalisation of cytokine state symptoms even against acute destructive process, and reduction of suppurative complication rate.
2 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTION OF DISTURBED STRUCTURAL-FUNCTIONAL PROPERTIES OF RED CELLS AND IMMUNE STATUS IN PATIENTS SUFFERING ACUTE PANCREATITIS | 2011 |
|
RU2458688C1 |
METHOD FOR TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS | 2006 |
|
RU2312663C1 |
METHOD OF TREATING EXPERIMENTAL PANCREATONECROSIS | 2012 |
|
RU2525015C2 |
METHOD FOR ADJUSTING IMMUNITY DISORDERS BY APPLYING COMBINED ADMINISTRATION OF OZONIZED PHYSIOLOGICAL SALT SOLUTION AND HELIUMNEON LASER TO DESTRUCTIVE PANCREATITIS PATIENTS | 2001 |
|
RU2194546C2 |
METHOD FOR PREDICTING PYOSEPTIC COMPLICATIONS IN PATIENTS POSSESSING ORGAN AND TISSUE INJURIES | 2006 |
|
RU2314532C1 |
METHOD FOR SELECTING A METHOD FOR TREATING ACUTE DESTRUCTIVE PANCREATITIS | 2018 |
|
RU2683291C1 |
METHOD OF CHOOSING THERAPEUTIC APPROACH TO PATIENTS WITH ACUTE DESTRUCTIVE PANCREATITIS | 2012 |
|
RU2497119C1 |
METHOD FOR PREDICTING THE OUTCOME OF ACUTE DESTRUCTIVE PANCREATITIS | 2016 |
|
RU2651030C1 |
METHOD FOR THERAPEUTIC APPROACH SELECTION FOR PATIENTS WITH ACUTE DESCTRUCTIVE PANCREATITIS | 2016 |
|
RU2625742C1 |
METHOD OF TREATING PANCREONECROSIS | 2011 |
|
RU2492527C2 |
Authors
Dates
2008-06-27—Published
2006-11-21—Filed